TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
MIST

Milestone Pharmaceuticals Inc

Healthcare · Biotechnology

0.8157$ -5.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Milestone Pharmaceuticals Inc (MIST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 182 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MIST
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
87 75 96 89 83 75 62 47 88 114 194 182
85 73 94 87 81 74 60 46 87 112 192 180
9.9 14 10 13 13 25 45 42 47 73 71 170
76 66 89 83 76 70 56 43 83 106 184 171
2.1 3.9 2.1 2.4 2.0 2.4 2.2 2.0 1.5 3.5 5.0 4.0
-0.6 – – – – 0.0 – – – 0.6 1.8 4.7
2.3 – – – – – – – – – – –
59 58 56 57 59 62 68 65 67 72 158 163
8.1 7.2 4.1 4.6 5.3 8.1 13 9.3 11 14 21 22
0.5 0.5 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.6 0.7 0.7
1.9 4.0 1.7 0.7 1.6 1.9 2.4 2.9 3.2 5.6 10 8.5
49 50 51 52 52 53 54 55 56 57 58 59
29 17 40 32 24 13 -6.1 -18 21 42 36 18
-312 -326 -336 -346 -355 -368 -388 -401 -413 -431 -457 -485
43 33 50 66 66 62 66 66 85 84 130 139

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?